References
Clinical Brochure: Menogaril (NSC 269148). National Cancer Institute, Bethesda, MD, 1983
McGovern J, Neil G, Denlinger R, Hall T, Crampton S, Swenberg J: Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent. Cancer Res 39: 4849–4855, 1979
Dorr A, Von Hoff D, Kuhn J, Schwartz R, Kisner D: Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic. Cancer Res 46: 2562–2565, 1986
Miller A, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 207–214, 1981
Fleming T: One sample multiple testing procedure for phase II clinical trials. Biometrics 38: 143–151, 1982
Sternberg C, Magill G, Cheng E, Hollander P: Phase II trial of menogaril in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol 11: 174–176, 1988
Author information
Authors and Affiliations
Additional information
Address for offprints: Southwest Oncology Group (SWOG-8513), Operations Office, 5430 Fredericksburg Road, Suite #618, San Antonio, TX 78229-6197, USA